Neurocrine Biosciences, Inc. (NBIX) Tops Q4 EPS by 1c
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) reported Q4 EPS of ($0.16) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
